OXOID’s Brilliance MRSA Agar is an ideal solution to the problem of MRSA screening.
It is both fast and reliable and is already being used by many sites, including those participating a year-long pilot screening programme currently running in Scotland; NHS Ayrshire & Arran, NHS Grampian and NHS Western Isles. Trials began in April 2008 and are backed by £7 million of Government investment in 2008-09.